Hoth Therapeutics CEO Robb Knie to Showcase Innovations at BIO-Europe 2025 in Vienna CEO Robb Knie of Hoth Therapeutics will present key clinical advancements at BIO-Europe 2025, focusing on innovative cancer therapies in Vienna.

Hoth Therapeutics CEO Robb Knie to Showcase Innovations at BIO-Europe 2025 in Vienna #Vienna #Austria #Hoth_Therapeutics #Robb_Knie #BIO-Europe

Hoth Therapeutics Announces Participation in Sequire Investor Summit Happening January 21-23, 2025 Hoth Therapeutics will be represented by CEO Robb Knie at the upcoming Sequire Investor Summit from January 21-23, 2025, in New York.

Hoth Therapeutics Announces Participation in Sequire Investor Summit Happening January 21-23, 2025 #United_States #New_York #Hoth_Therapeutics #Robb_Knie #Sequire_Investor_Summit